Updated 1 week ago ·
Published on 9 Jan 2023 11:00PM ·
ANGLO-SWEDISH pharmaceuticals giant AstraZeneca today agreed to buy US biotech company CinCor for US$1.8 billion (RM7.92 billion), expanding further into the field of heart and kidney drugs.
The takeover marks the latest push by Astra chief executive Pascal Soriot to bolster the Covid vaccine maker’s pipeline of new products.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!
Sign up or sign in here to comment.
